Propranolol HCI 40mg 1 film-coated tablet [Prescription Required]

REMINDER: A doctor&rsquo,s prescription is required to purchase this product. To avoid delay in delivery or cancellation of your order ,(before the item is SHIPPED), please email a copy of your prescription (.jpeg or .pdf file format) to ,OnlinePharmacy@watsons.com.ph ,with your order number after Checkout. Our pharmacist will also get in touch with you to validate your prescription. Please be ready to show your original prescription upon claiming/delivery of your order.

 ,

 ,

 ,

Control of hypertension, management of pheochromocytoma (should only be started in the presence of effective alpha blocker), management of angina pectoris, adjunctive management of thyrotoxicosis and thyrotoxic crisis, long term prophylaxis after recovery from acute myocardial infarction, control of cardiac arrhythmias, prophylaxis of migraine, management of essential tremor, control of anxiety and anxiety tachycardia, management of hypertrophic obstructive cardiomyopathy, prophylaxis of upper gastrointestinal bleeding in patients with portal, hypertension and oesophageal varices

Place of Origin

Philippines

Product Usage

• For Oral Administration For Oral Administration Adults Hypertension: Initially 40 mg two to three times daily, which may be increased by 80 mg per day at weekly intervals according to response. The usual dose range is 160 to 320 mg per day. With concurrent diuretic or other antihypertensive drugs, a further reduction of blood pressure is obtained.Angina, migraine and essential tremor: A starting dose of 40 mg two or three times daily may be increased by the same amount at weekly intervals according to patient response. An adequate response in migraine is usually seen in the range 80 to 160 mg/day and in angina and essential tremor in the range 120 to 240 mg/day. Arrhythmias, hypertrophic obstructive cardiomyopathy and thyrotoxicosis: A dosage range of 10 to 40 mg three or four times a day usually achieves the required response. Post-myocardial infarction: Treatment should start between days 5 and 21 after myocardial infarction, with an initial dose of 40 mg four times a day for 2 or 3 days. In order to improve compliance, the total daily dosage may thereafter be given as 80 mg twice a day. Hyperthyroidism: The dose is adjusted according to clinical response. Portal Hypertension: Dosage should be titrated to achieve approximately 25% reduction in heart rate at rest. Dosing should begin with 40 mg twice daily, increasing to 80 mg twice daily depending on heart rate response. If necessary, the dose may be increased incrementally to a maximum of 160 mg twice daily. Phaeochromocytoma: Propranolol Hydrochloride (Indirin) is used only in the presence of effective alpha-blocker. Pre-operative: 60 mg daily for 3 days is recommended. Non-operable malignant cases: 30 mg daily. Hepatic Impairment: The bioavailability of propranolol may be increased in patients with hepatic impairment and dose adjustments may be required. In patients with severe liver disease (e.g. cirrhosis), a low initial dose is recommended (not exceeding 20 mg three times a day) with close monitoring of the response to treatment (such as the effect on heart rate). Renal Impairment: Concentrations of propranolol may increase in patients with significant renal impairment and hemodialysis. Caution should be exercised when starting treatment and selecting the initial dose. As with the other beta-adrenoreceptor blocking agents, treatment should not be discontinued abruptly. The dosage should be withdrawn gradually over a period of 7 to 14 days. Either the equivalent dosage of another beta-adrenoceptor blocker may be substituted or the withdrawal of propranolol should be gradual. Patients should be followed during withdrawal especially those with ischaemic heart disease. The risk/benefit of stopping beta blockade should be made for each patient. 
  Elderly Evidence concerning the relationship between blood level and age is conflicting. Propranolol should be used to treat older people with caution. It is suggested that treatment should start with the lowest dose. The optimum dose should be individually determined according to clinical response.
  Pediatrics Arrhythmias: Dosage should be determined according to the cardiac status of the patient and the circumstances necessitating treatment. The dose should be adjusted individually and the following is a guide: Children and adolescents: 0.25-0.5 mg/kg three to four times daily, adjusted according to clinical response. Migraine: Under the age of 12: 20 mg two or three times daily. Over the age of 12: the adult dose

Ingredients

Propranolol HCl and other components

Warnings

Contraindications: Contraindications: Should not be given to patient with history of bronchial asthma or bronchospasm; should not be given to patient with any of the following: known hypersensitivity to the substance; bradycardia; cardiogenic shock; hypotenion; metabolic acidosis; after prolonged fasting; severe peripheral arterial circulatory disturbances; second or third degree heart block; sick sinus syndrome; untreated (with alpha adrenoreceptor antagonists) pheochromocytoma; uncontrolled heart failure

Width

1

Height

1

Depth

1